Introduction
Odontogenic infections represent the most common type of head and neck infection, with abscesses (localized purulent collections) requiring surgical drainage for complete resolution. While antibiotics are essential for systemic infection control, surgical drainage remains the definitive treatment for established abscess (purulent collection), as antibiotics penetrate poorly into pus (pH 5-6, protein-rich, cellular debris present). This review addresses the clinical assessment of abscess versus cellulitis, indications for incision and drainage (I&D), technical aspects of I&D procedure, drain selection and management, and postoperative antibiotic protocols.
Diagnosis: Abscess Versus Cellulitis
Clinical distinction between localized abscess (amenable to I&D) and diffuse cellulitis (initially managed medically with antibiotics) is critical for treatment planning. Abscess characteristics include: well-demarcated swelling with defined margins, fluctuance on palpation (tissue gives way under gentle pressure, indicating fluid accumulation), smooth surface without surrounding inflammation, localized pain with point tenderness, and spontaneous drainage (purulent exudate) either intraorally or extraorally. Abscess typically develops 3-7 days after initiating infection and represents the body's attempt to wall off and control infection.
Cellulitis characteristics include: poorly demarcated margins with inflammation spreading into surrounding tissue, diffuse induration (hardness) without fluctuance, elevated temperature, warm erythematous (red) surface, systemic symptoms (fever, malaise, chills), and lymphadenopathy (swollen regional lymph nodes). Cellulitis spreads along tissue planes and fascial spaces without localization; early infection typically presents as cellulitis before abscess formation occurs. Imaging assessment distinguishes localized collection from diffuse infection: ultrasonography demonstrates hypoechoic (dark) collections indicating purulent accumulation, MRI shows T2-hyperintense (bright) collections on T2-weighted imaging, and CT with contrast enhancement shows non-enhancing central region (necrotic debris, pus) surrounded by enhancing tissue (inflammatory edema, viable tissue). Intraoral ultrasonography (using high-frequency 18-22 MHz probes) effectively identifies small buccal/lingual collections.Indications for Incision and Drainage
Surgical drainage is indicated for: (1) clinically apparent abscess with fluctuance, (2) imaging-confirmed fluid collection, (3) failure to improve with antibiotics alone within 48-72 hours, (4) airway-compromising swelling, (5) fever unresponsive to antibiotics, and (6) immunocompromised patients (diabetes, HIV, chemotherapy) with documented infection. Contraindications include: uncomplicated cellulitis (medical management only), bacteremia with sepsis (IV antibiotics and potentially blood cultures before drainage), and patient instability preventing safe operative intervention.
Technical Aspects of Incision and Drainage
Site Selection and Access
Site selection focuses on identifying the area of maximum fluctuance or imaging-confirmed collection. Extraoral drainage is preferred over intraoral when: (1) collection is in the sublingual space (risk of airway obstruction with intraoral drainage), (2) collection extends into cervical fascia or lower face, (3) patient compliance with oral rinses is questionable, or (4) collection is large (>2 cm) with significant systemic involvement. Intraoral drainage is acceptable for localized buccal collection with good visualization and patient cooperation.
Stab incision technique (preferred over larger incision for small collections) involves: (1) selection of incision site over the area of maximum fluctuance (digital pressure identification), (2) sterile preparation of the site (chlorhexidine 0.12% or povidone-iodine 10% with alcohol-based carrier), (3) local anesthesia administration (noting that anesthetic may not effectively anesthetize infected tissue due to acidic environment; additional anesthetic may be required or brief topical anesthesia with sprayed lidocaine), and (4) incision creation with a #15 or #11 scalpel blade through mucosa/skin and immediately underlying subcutaneous tissue (typically 5-10 mm incision length, just large enough for pus drainage and drain placement).Blunt Dissection
Blunt dissection following initial incision identifies the abscess cavity margin and breaks up loculations (separate pus pockets). Using a hemostat or small periosteal elevator, gentle spreading motions in multiple directions (vertical, transverse) enlarge the cavity and ensure drainage of purulent material. Excessive vigorous dissection traumatizes surrounding tissue and increases bleeding; motion should be deliberate and controlled. Finger palpation (gloved) can also be used to identify cavity borders and loculations once initial access permits. Purulent material should be submitted for aerobic/anaerobic culture if available; collection in anaerobic culture tube is preferred for accurate organism identification and anaerobic susceptibility testing.
Drain Placement
Drain placement prevents premature incision closure and ensures continued drainage during the inflammation resolution phase. Penrose drain (rubber tubing, diameter 1/4-1/2 inch) remains the standard drain choice for small-to-moderate collections. Placement technique: (1) suture one end of the drain to the skin/mucosal margin using 3-0 or 4-0 suture material, (2) ensure drain courses through the collection cavity (can gently manipulate with mosquito clamp), (3) do not occlude drain lumen with surrounding tissue, and (4) secure free end externally (safety pin placement prevents drainage tube migration).
Drain duration typically ranges from 24-48 hours (for small collections with uncomplicated access) to 5-7 days (for larger collections or deep spaces). Daily or twice-daily drain irrigation with normal saline (60 mL syringe, gentle irrigation) maintains patency. Drain should be removed when: (1) minimal-to-no drainage (measure daily output; <5 mL serous drainage indicates healing), (2) collection has resolved, and (3) patient demonstrates no fever or systemic symptoms.
Microbiological Considerations
Odontogenic abscess cultures typically yield polymicrobial infections; mean bacterial count is 3-4 organisms per specimen. Anaerobic bacteria are isolated in 80-90% of odontogenic infections and include: Prevotella species (40-60% of positive cultures), Fusobacterium nucleatum (30-50%), Peptostreptococcus species (25-40%), and Clostridium species (<10%). Aerobic organisms include: Streptococcus viridans and other streptococci (25-35%), Staphylococcus aureus (15-25%, particularly in hospital-acquired infections), and Enterococcus species (10-15%).
Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly isolated in healthcare-associated odontogenic infections; risk factors include recent hospital admission, prior antibiotic therapy, and immunocompromise. Standard swab culture has suboptimal sensitivity for anaerobes (oxygen exposure kills organisms); anaerobic transport tubes (gassed-out tubes with oxygen-free medium) improve isolation rates by 25-40%. Direct needle aspiration is the gold standard culture method, providing highest sensitivity for anaerobes.
Antibiotic Protocols
Empiric therapy for odontogenic abscess pending culture and susceptibility should cover oral anaerobes and aerobes. First-line agents include:1. Amoxicillin-clavulanate (875-125 mg orally twice daily for 7 days): covers beta-lactamase-producing anaerobes (Prevotella, Fusobacterium) and aerobes; resistance emerging in some regions but remains standard first-line therapy.
2. Clindamycin (300-600 mg orally every 6 hours for 7 days): excellent anaerobic coverage with good oral bioavailability; reserve for penicillin-allergic patients or communities with high amoxicillin resistance.
3. Fluoroquinolone + metronidazole (levofloxacin 750 mg daily + metronidazole 500 mg three times daily): appropriate for moderate infections with systemic symptoms; levofloxacin covers aerobes and some anaerobes (including Prevotella), metronidazole covers obligate anaerobes.
IV therapy is reserved for severe infections with systemic toxicity, immunocompromised patients, or airway compromise: ampicillin-sulbactam (3 g every 6 hours) or piperacillin-tazobactam (4.5 g every 6-8 hours) provide excellent broad-spectrum coverage. Duration is typically 3-5 days IV followed by transition to oral therapy for 7-10 days total. Culture-directed therapy adjusts empiric choice based on susceptibilities; adjust therapy when susceptibilities identify resistant organisms. Minor modifications are frequently unnecessary if patient demonstrates clinical improvement (fever resolution within 24-48 hours, swelling reduction, pain improvement).Postoperative Management
Pain control follows standard postoperative protocols: NSAIDs provide superior pain control for inflammatory conditions; ibuprofen 600-800 mg every 6-8 hours is preferred. Opioid medications are typically unnecessary and should be minimized. Oral rinses with chlorhexidine 0.12% (30-second rinses, 4-6 times daily) promote drainage and prevent secondary infection. Rinses should begin 24 hours post-drainage (prior to that, avoid disturbing drain and fresh clot). Normal saline rinses (1/2 teaspoon salt in 8 oz water) are an acceptable alternative for patients unable to tolerate chlorhexidine. Drain care includes: daily observation of drainage character (purulent vs. serous), measurement of drainage volume (document on patient chart), gentle irrigation if drainage decreases prematurely, and scheduled removal when output is minimal (<5 mL daily). Drain removal is typically a 30-second office procedure; anesthesia is usually unnecessary given minimal sensation. Follow-up examination at 24-48 hours post-drainage assesses: fever resolution, swelling reduction, drainage characteristics, and early identification of complications. Systemic improvement despite fever is favorable; persistent fever >24 hours despite drainage and antibiotics suggests inadequate source control (additional loculations) or healthcare-associated organism (MRSA, resistant gram-negative organism) requiring susceptibility-directed therapy adjustment.Complications of Abscess and I&D
Airway obstruction occurs with sublingual space abscess (extending into neck) or large buccal space abscess (causing tissue swelling). Early recognition includes: progressive difficulty swallowing, changes in voice quality (muffled voice), pooling of saliva, stridor (audible breathing difficulty), or severe dyspnea. Management requires emergency airway assessment (fiberoptic visualization if time permits) and potential intubation or tracheostomy for severely compromised airways. I&D alone may not immediately restore airway; aggressive IV antibiotic therapy, dexamethasone (10 mg IV single dose), and possible ICU monitoring are necessary. Spreading cellulitis despite I&D and antibiotics indicates inadequate source control or highly virulent organism. Broader imaging (CT of the surgical region) identifies additional loculations or occult collections requiring drainage. Chronic draining fistula rarely develops if adequate source control (removal of causative tooth or endodontic therapy) is not performed. Fistulas (epithelialized tracts) allow continued drainage and prevent site closure; definitive treatment requires source identification and elimination.Conclusion
Incision and drainage remain essential surgical procedures for managing established odontogenic abscesses, providing immediate source control that antibiotics alone cannot achieve. Systematic site assessment, meticulous aseptic technique, appropriate drain selection, and culture-directed antibiotic therapy optimize outcomes and minimize long-term morbidity. Recognition that abscess represents a potentially serious condition requiring prompt definitive drainage, combined with appropriate antimicrobial therapy, enables dentists and oral surgeons to provide comprehensive infection management and prevent serious complications including airway obstruction, descending necrotizing mediastinitis, and cavernous sinus thrombosis.